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Beta power suppression in the basal ganglia is stronger during movements that require high 
force levels and high movement effort but it has been difficult to dissociate the two. We 
recorded scalp EEG and basal ganglia local field potentials in Parkinson’s disease patients 
(11 STN, 7 GPi) ON and OFF dopaminergic medication while they performed a visually-
guided force matching task using a pen on a force-sensitive graphics tablet. Force 
adjustments were accompanied by beta power suppression irrespective of whether the force 
was increased or reduced. Before the adjustment was completed, beta activity returned. High 
beta power was specifically associated with slowing of the force adjustment. ON medication, 
the peak force rate was faster and cortico-basal ganglia beta phase coupling was more readily 
modulated. In particular, phase decoupling was stronger during faster adjustments. The 
results suggest that beta power in the basal ganglia does not covary with force per se, but 
rather with a related factor, the absolute force rate, or a more general concept of movement 
effort. The results also highlight that beta activity reappears during stabilization of isometric 
contractions, and that dopamine-related suppression of cortico-basal ganglia beta coupling is 
linked to faster force adjustments. 
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DBS Deep brain stimulation 
EEG Electroencephalogram 
GPi Internal globus pallidus 
ISPC Intersite phase clustering 
LFP  Local field potential  















Mounting evidence suggests the basal ganglia are involved in regulating movement vigour 
(Da Silva et al., 2018; Mazzoni et al., 2007; Turner and Desmurget, 2010; Yttri and Dudman, 
2016). Direct recordings from basal ganglia targets in patients have shown that reciprocal 
changes in beta and gamma band activities in the local field potential (LFP) covary with the 
production of different force levels (Tan et al., 2013) as well as with movement size and 
speed (Brücke et al., 2012; Joundi et al., 2012). Beta power in motor cortex and the basal 
ganglia is suppressed during ballistic movements (Brücke et al., 2008; Kilavik et al., 2013; 
Kühn et al., 2004), and especially so during vigorous movements (Tan et al., 2015, 2013), but 
during sustained, stable contractions, motor cortical beta power and cortico-muscular 
coherence is increased (reviewed in Kilavik et al., 2013). One prominent hypothesis is that 
beta oscillations promote the status quo (Engel and Fries, 2010; Gilbertson et al., 2005) – or, 
in other words, the stability of the current state. Interestingly, beta oscillations reappearing 
after a movement are also modulated by sensory feedback (Tan et al., 2014a, 2014b; 
Torrecillos et al., 2015). Most motor assessments involve either ballistic movements or 
sustained force and thus to date it is unknown how basal ganglia beta oscillations relate to 
small adjustments of otherwise sustained, isometric forces. Yet small movements are 
impaired early in Parkinson’s disease, as evinced by the deterioration in handwriting that is 
often the first symptom of the condition (Pinto and Velay, 2015; Rosenblum et al., 2013). 
Here we recorded the LFP in the subthalamic nucleus (STN) or globus pallidus interna (GPi) 
whilst Parkinsonian patients made visually-cued, low-force isometric force adjustments with 
a hand-held pen on a force-sensitive tablet. This allowed us to contrast spectral changes 
during isometric force increases and reductions. In particular, the paradigm enabled us to 
explore two contrasting hypotheses. The first is that beta oscillations are inversely related to 













increased power during force reductions. Alternatively, beta oscillations may be related to a 
directionless measure, such as the rate of any changing muscle contraction, or the effort 
made, rather than the generated force per se (Tan et al, 2015). In this case we should find that 
beta power is suppressed irrespective of the direction of the force change. In addition, by 
using the same paradigm both off and on dopaminergic medication, we were able to test the 
hypothesis that the pattern of basal ganglia activity associated with finely controlled motor 
adjustments differs according to dopaminergic status. Here, we were particularly interested in 
the balance between beta reactivity locally in the STN and GPi and in the long-range 
coupling between the STN/GPi and cortex (Cassidy et al., 2002; Litvak et al., 2011; van Wijk 




Eighteen patients with idiopathic Parkinson’s disease (mean disease duration of 10 ± (STD) 5 
years, mean age 62 ± 7 years, 16 males) provided written informed consent to take part in this 
study, which was approved by the local ethics committees. Clinical details of the patients are 
given in Supplementary Table 1. The patients showed 58 ± (STD) 14% improvement in the 
motor section of the Unified Parkinson’s Disease Rating Scale (UPDRS) on treatment with 
levodopa, indicating good responsiveness to medication. 
All patients were implanted with bilateral DBS electrodes as a prelude to therapeutic high-
frequency stimulation for advanced Parkinson’s disease with motor fluctuations and/or 
dyskinesia 3-6 days prior to the recording. The target for the electrodes were the STN in 
eleven patients and the GPi in seven patients.  
DBS electrode extension cables were externalized through the scalp to enable recordings 













operation up to 7 days later. The electrode implantation procedure has been described 
previously (Foltynie and Hariz, 2010). The macroelectrodes implanted were Model 3389 
TM 
from Medtronic Neurologic Division and Model DB-2201 
TM 
 and DB-2202 
TM 
 from Boston 
Scientific. Surgeries and recordings were performed at one of the following three sites: 
King’s College hospital, London, University College hospital, London, or the John Radcliffe 
hospital, Oxford, UK. Several cases have been previously reported in other studies (Fischer et 
al., 2017a, 2017b). 
 
Experimental paradigm 
LFPs were recorded while patients performed a visually-guided force matching task. Each 
experimental run lasted 120s, in which the size of a blue target box (contour width = 8 
pixels), which denoted the target force, randomly changed on average every 3.7s  2.2s (Fig. 
1A). The target force was on average 1.58 N  0.13 N, ranging from 0.31 to 2.79 N. 
Patients were asked to control the size of a black box (contour width = 2 pixels) that was 
centered on the same point of the screen as the target box by varying the force of a pen on a 
graphic tablet (Wacom Intuos CTL-480, small). The box expanded with increasing force, and 
patients were instructed to match the size of the target box as precisely as possible. A similar 
setup has previously been introduced to assist rehabilitation protocols and assess motor 
performance (Confalonieri et al., 2012; Kirchner et al., 2011). The task was performed with 
the dominant hand, but if patients had severe tremor or rigidity in this hand it was performed 
with the non-dominant one (in 6 of 18 patients). All patients were recorded ON medication, 
and a subset of 11 patients were also recorded OFF medication (5 STN, 6 GPi). 6 of the 11 













In each condition, four consecutive runs were recorded with breaks in-between ranging 
between several seconds to minutes depending on fatigue. Thus, patients performed the task 
for eight minutes in total, or twice this if both medication states were tested. In half of all 
runs, a red distractor box was present, which randomly differed in size from the target box. 
Patients were instructed to ignore the red box and focus on matching the size of the black box 
to the target box, which they successfully did. A demo of the task including the distractor box 
is shown in a video available on YouTube (https://www.youtube.com/watch?v=v7EbPjZB-
dM). As we focus on motor dynamics in this study, we pooled the data across all runs.  
 
Data recording 
LFP and EEG signals were recorded with a TMSi Porti amplifier (2048 Hz sampling rate, 
TMS International, Netherlands). The timings of target changes were registered with a light-
sensitive sensor attached to the corner of the presentation laptop. The software was 
programmed to produce a brightness pulse under the sensor at the onset of changes in the 
target size. The behavioural data (target force and applied force, sampled at 5 ms) were 
written to a separate text-file stored on the presentation laptop and later merged with the 
LFP/EEG recordings in MATLAB (RRID:SCR_001622, v. 2016a, The MathWorks Inc., 
Natick, Massachusetts) by interpolating and resampling the behavioural data. EEG electrodes 
were placed over (or close to if sutures had to be avoided) Fz, Cz, Pz, Oz, C3 and C4 
according to the international 10-20 system. For one patient, the electrode over ipsilateral 















The force matching task required continuous control over hand and arm muscles. It consisted 
of stable periods and isometric force modulations for which a precise adjustment of muscle 
activity was required. Examples of the pen force recordings are shown in Fig. 1B. The start 
and end points of each force adjustment were tagged manually to ensure they were correctly 
identified. Sometimes these adjustments involved over- or undershoots into the opposite 
direction of the instructed force change. These were also tagged so they could be analysed 
separately. To get robust estimates of the central tendency of reaction times or the peak force 
rate, the median across trials was computed.  
 
Analysis of EEG and LFP recordings 
Frequency-band and channel selection  
The data were first down-sampled to 1000 Hz and artefacts in the LFP or EEG recordings 
were excluded by visual inspection (16% of the data). EEG electrodes over the contra- and 
ipsilateral motor cortex (C3 and C4) were re-referenced to the average of all recorded EEG 
channels (Fz, Cz, Pz, Oz, C3 and C4). To obtain spatially focal bipolar signals of the 
recorded LFPs, the difference between the raw signal of two neighbouring DBS electrode 
contacts was computed. If single channels saturated or were inactive (in 6 of 36 electrodes), 
the remaining surrounding contacts were subtracted instead. We included an additional 
bipolar configuration by calculating the difference between the lowest and highest contacts, 
as in some cases beta modulation across contiguous bipolar contacts was indistinct. For 8 of 
36 electrodes the strongest modulation was in the configuration spanning the widest distance. 
To assess if modulation was present during force adjustments, we first computed the power 













continuous Morlet wavelet transforms (fieldtrip-function ft_freqanalysis, 
RRID:SCR_004849, Oostenveld et al., 2011). The number of wavelet-cycles was 6 for 
frequencies below 50 Hz and 12 for frequencies above 50 Hz. To investigate in which 
frequency range the power modulation was strongest, for each subject the median across all 
force adjustments was computed, averaged across all bipolar signals for each electrode, and 
smoothed with a 0.1s sliding window. Significance tests based on a cluster-based permutation 
procedure for multiple comparison correction (see below) showed strongest modulation 
between 15-30 Hz just before the mid-point of the force adjustment (Fig. 2). To select one 
bipolar signal from each electrode for further analyses, only ON medication trials were 
considered as not all patients were recorded OFF medication and as beta modulation is 
stronger ON medication (Doyle et al., 2005). For each electrode, the channel with the 
strongest force adjustment-related 15-30 Hz beta decrease in this range was pre-selected. This 
was based on all trials in the ON medication condition irrespective of whether the force had 
to be increased or reduced. The channel with the highest modulation was identified by 
computing t-scores (across all adjustments) of 15-30 Hz beta power averaged across a -
300:100ms window around the mid-points of the adjustments, according to the significant 
cluster shown in Fig. 2. The instantaneous phase and power of 15-30 Hz beta oscillations was 
then extracted with a Hilbert-transform of the filtered data (Butterworth filter, filter order = 4, 
passed forwards and backwards, fieldtrip-function ft_preproc_highpassfilter and 















Assessment of force adjustment-related power changes 
To assess how power changed from the beginning to the end of a force adjustment despite 
variable durations, we subdivided each adjustment period into three segments: 1) 1s before 
the adjustment started until the start, 2) from the start until the end, 3) from the end of the 
adjustment until 1s afterwards. Each of these three segments was divided into 30 equidistant 
points, and then the median of beta power at these points was computed across all 
adjustments to get a robust estimate. Thus, for adjustments that took relatively long, the 
distances between the 30 points were larger than when they were short. This way, we 
evaluated how beta changed throughout different phases of the force adjustments, 
independent of how long they took. Before computing cluster-based permutation statistics 
(see below) smoothing was applied (moving average window size: 5 samples, MATLAB 
function smooth). 
To test if beta increased significantly before completion of the adjustment, we computed 
Pearson’s linear correlation coefficients for each patient based on the 30 points between the 
start and end of the force adjustment (x = bin number, y = beta power). The resulting 
coefficients were Fisher’s Z-transformed and then tested against zero to find out if a 
relationship existed at the group level. 
 
 
Correlation between beta power and force  
In examples of individual trials, we noticed plateaus in the force adjustment when beta power 
was high, indicating slowing (Supplementary Fig. 1). To assess at the group level if beta 
power correlates with the absolute force rate (and as control analysis also with the force 













divided each adjustment into 30 equal bins. This resulted in [nr. of adjustments*30] values 
for both variables, which were pooled to compute one within-subject correlation coefficient 
for each patient. The resulting correlation coefficients were Fisher’s Z-transformed to test if 
they differed significantly from zero at the group level. 
As we observed a beta power increase towards the end of an adjustment, just before the 
adjustment comes to a halt (thus coinciding more likely with a lower force rate), this 
correlation may be mainly driven by beta power being higher and force rates being lower 
towards the end. To show that this alone could not explain the correlation, we tested if the 
correlation is also significant compared to a permutation distribution, which was created by 
keeping the order of the 30 bins intact for each trial but permuting the association between 
beta power and the force measurement across trials. This ensured that beta power from late 
parts of an adjustment were always paired with absolute force rates from another late part of 
an adjustment. After performing this permutation 500 times we tested if the original 
correlation coefficient was more extreme than the permuted ones (computing two-tailed p-
values according to Ernst (2004)).   
 
 
Assessment of cortico-basal ganglia coupling 
Coupling strength was evaluated by computing inter-site phase-clustering values (ISPC, 
Lachaux et al., 2000) based on the differences in beta phase between the concomitant EEG 
and LFP recordings (           ). The phase was obtained by computing the Hilbert-
transform of the 15-30 Hz filtered signals. ISPC values correspond to the length of the 
average vector of phase differences represented as vectors with length one on a unit circle (n 
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Note that the amplitude of the signal does not contribute to the ISPC estimate. However, if 
beta power drops too low in one or both of the signals, phase is poorly defined and coupling 
will necessarily drop. 
 
 
Probability of beta bursts during movements and average amplitude 
We also investigated whether movement-related power changes were associated with 
modified beta burst probabilities or differences in beta burst peak amplitudes. Beta bursts 
were classified as periods where the 15-30 Hz amplitude exceeded a threshold defined as the 
75% percentile of the resting baseline recorded ON medication (Tinkhauser et al., 2017). 
Only suprathreshold events exceeding a duration of 100ms were classified as bursts because 
anything shorter would contain less than two beta cycles. We tested specifically how the 




Cluster-based permutation test 
All statistical tests for which multiple time bins or multiple time and frequency bins (as in 
Fig. 2) were tested were corrected for multiple comparisons by using a cluster-based 
permutation correction approach (Maris and Oostenveld, 2007): A permutation distribution 













Suprathreshold-clusters (pre-cluster threshold: P<0.05) were obtained for the original 
unpermuted data and for each permutation sample by computing the z-scores relative to the 
permutation distribution. If the sum of the absolute z- scores within any original 
suprathreshold-cluster exceeded the 95th percentile of the sums of absolute z-scores from the 
2000 largest suprathreshold-clusters obtained from the permutation distribution, it was 
considered statistically significant. The procedure corrects for multiple comparisons by 
comparing not each point individually but by comparing by the largest number of contingent 
significant points, which should be lower in the permuted data if the cluster did not occur just 
by chance. Any other tests that required multiple comparison correction but did not contain 
contingent time- or frequency bins were corrected using FDR correction. 
 
ANOVAs and pairwise comparisons 
To ensure that pooling of the STN and GPi recordings was justified, we computed the 
following ANOVAs to assess if beta power was modulated similarly in recordings from the 
STN and the GPi: The first ANOVA only included data from the ON medication condition 
(n=18) with nucleus as between-subjects factor and hemisphere (contra-/ipsilateral) and 
adjustment type (force increase or reduction) as within-subjects factor. 
The second ANOVA only included the subset of patients where both ON and OFF 
medication conditions were recorded (n=11). It contained again the between-subjects factor 
nucleus (STN/GPi) and two factors (medication: ON/OFF, and adjustment: 
increase/reduction). If the sphericity assumption was violated, Greenhouse-Geisser correction 
was applied. Pairwise comparisons were performed with paired t-tests or Wilcoxon signed 
rank tests (denoted as WSR-test) if the normality assumption was violated (assessed with a 














Correlations between peak force rates, power and coupling 
To investigate the relationship between peak force rates versus beta power or beta phase 
coupling ON and OFF medication, we computed robust Spearman’s correlation coefficients. 
The resulting coefficients were Fisher’s Z-transformed before testing if they were 
signiﬁcantly different from zero on a group level. Additionally, we controlled for the relative 
contribution of power changes by computing partial correlations between ISPC values and 
peak force rates.   
Results 
Behavioural results 
The peak force rate was higher when the force was reduced than when it was increased. This 
was found to be statistically significant when patients were OFF medication (p=0.011, t10=-
3.1). It was not strictly statistically significant, but a trend was also present ON medication (p 
= 0.065, t17=-2.0, Fig. 1C). Comparing peak force rates between the ON and OFF medication 
condition, we found that the peak rate during force increases was significantly higher when 
patients were medicated (p = 0.017, t10 = 2.9). The peak rate during force decreases did not 
differ significantly between medication states (p = 0.278, t10 = -1.1).  
ON medication, the average duration of the adjustment was 835ms and 645ms for force 
increases and reductions respectively. OFF medication, it was 824ms and 676ms (no 
significant differences after FDR correction for multiple comparisons, Fig. 1C). Reaction 
times were significantly faster for force increases compared to reductions when patients were 
ON medication (ON: p = 0.005, t17=-3.3; OFF: p = 0.895, t10=-0.1, Fig. 1C). 
The average force preceding force increases was 1.30  0.12 and 1.83  0.17 N when the 
adjustment was completed, while for force reductions it was 1.81  0.16 and 1.26  0.12 N. 
The average amount of force change was similar for force increases and reductions 
















15-30 Hz beta power (averaged across all channels) decreased during force adjustments  
As a first step, before focussing on the bipolar signals with the strongest beta modulation, we 
investigated LFP power changes in the ON medication condition averaged across all bipolar 
channels and all adjustments (force increases and reductions). We aligned the data to the 
midpoint of each force adjustment (= the mid-point between two black crosses in Fig. 1B) 
and found a significant power decrease relative to the median power of each session in all 
contralateral structures, and even in the ipsilateral STN/GPi and M1 (Fig. 2). As the power 
decrease in subcortical structures was most pronounced between 15-30 Hz just before the 
midpoint of the force adjustment, we focussed all further analyses on channels showing the 
strongest 15-30 Hz beta decrease within a -300:100ms window around the midpoint of the 
force adjustments. These contacts are presumed to have picked up activity related to motor 
control, and thereby to be closest to the dorsolateral sensorimotor region of the STN (Horn et 
al., 2017). In the OFF medication condition recorded in a subgroup, a similar beta power 
decrease occurred (Supplementary Fig. 2). Also when the data is aligned to the cue change, 
the beta decrease looks similar (Supplementary Fig. 3). No significant power modulation 
was observed in the gamma frequency range (Supplementary Fig. 4) 
 
During force adjustments, beta power was lower than the resting baseline activity  
We tested whether beta power during force adjustments was suppressed relative to a baseline 
activity at rest (recorded in both ON and OFF medication states). Power obtained from the -
300:100ms window around the midpoint of the force adjustments (as used for channel pre-













in the ON medication condition (contra LFP: -14%, p = 0.013, t17 = -2.8; ipsi LFP: -13%, p = 
0.007, t17 = -3.1; contra M1: -12%, p = 0.037, t17 = -2.3; ipsi M1: -17%, p = 0.007, t16 = -3.1) 
and in all channels apart from the ipsilateral STN/GPi in the OFF medication condition 
(contra LFP: -12%, p = 0.014, WSR-test (n=11); ipsi LFP: -3.0%, p = 0.102, WSR-test 
(n=11); contra M1: -20%, p < 0.001, t10 = -5.8; ipsi M1: -21%, p = 0.003, t9 = -4.0) 
 
We also compared if the holding period, within which a stable force had to be applied, 
differed from the resting baseline. A 400ms long window starting 400ms before the cue 
changed was examined. No significant differences between the stable period and the resting 
baseline were found (ON: contra LFP: -0.5%, p = 0.939; ipsi LFP: -7.1%, p = 0.286; contra 
M1: -3.3%, p = 0.521; ipsi M1: -9.2%, p = 0.112; OFF: contra LFP: 5%, p = 0.831; ipsi LFP: 
3%, p = 0.520; contra M1: -5.5%, p = 0.285; ipsi M1: -9.3%, p = 0.215). 
For all further analyses, for example contrasting force increases and decreases, we obtained 
relative within-condition power changes by normalizing the data to the median of each 
recording session to minimize heteroscedasticity between conditions. 
 
Beta power decreased more when the force was reduced than when it was increased, and 
behaved similarly in the two nuclei 
Next, we assessed if power changes differed when the force was increased or reduced. We 
computed a 2x2 repeated-measures ANOVA with the adjustment-related beta power change 
as dependent variable (averaged within the -300:100ms window around the midpoint of force 
adjustments, normalized within each session), and subcortical nucleus (STN/GPi) as 
between-subjects factor (ON medication only). The two within-subjects factors were change 
direction (CD: force increase/reduction) and hemisphere (HS: contra/ipsilateral). The 













change direction and hemisphere only came close to being significant (HS: p = 0.025, CD: 
p=0.204, CD *nucl: p = 0.325, CD*HS: p = 0.080, HS*nucl: p = 0.683, CD*HS*nucl: p = 
0.853, nucl: p = 0.819, see Supplementary Table 2 for F-statistics). When directly 
comparing the two beta power time courses using a cluster-based permutation procedure to 
correct for multiple comparisons over time, we saw a difference between force increases and 
reductions in the contralateral LFP (Fig. 3, red shaded areas): Beta power stayed more 
strongly suppressed throughout the adjustment when the force was reduced compared to 
when it was increased. Considering that the peak force rate during force reductions was faster 
than during increases (Fig. 1C), the observed power difference may be related to differences 
in adjustment speed, which will be investigated in more detail below. 
A second ANOVA was computed to compare if the relative beta power suppression differed 
between the two medication states in the reduced subset of patients where both ON and OFF 
medication conditions were recorded (n=11). It contained again two factors (MED: ON/OFF, 
and CD: increase/reduction) and the between-subjects factor nucleus (STN/GPi). The 
dependent variable was the amount of beta suppression in the contralateral STN/GPi. Only 
the main effect CD was significant (CD: p=0.007; MED: p = 0.908, MED*nucl: p=0.947, 
CD*nucl: p = 0.402, CD*MED: p=0.436, CD*MED*nucl: p=0.105, nucl: p=0.646). The fact 
that none of the effects involving the between-subjects factor nucleus were significant 
suggests that beta modulation related to the force adjustment was similar in the STN and the 
GPi. This similarity is also shown in Supplementary Fig. 5, which depicts the beta power 














Trial-averaged beta power gradually began recovering from suppression already before the 
force adjustment was completed 
Fig. 3 shows that beta power dropped already about 300ms before the force adjustment 
started. Beta power suppression was maximal at the beginning of the force adjustment and 
began to recover gradually immediately afterwards – already before the change in force was 
completed.  
To assess if beta significantly began recovering before the force change was completed, we 
computed Pearson’s correlation coefficients for each patient based on the power at the 30 
points between the start and end of the adjustment (x: bin number, y: beta power). We first 
tested if the Fisher’s Z-transformed correlation coefficients differed from zero at the group 
level in the ON medication condition and included all adjustments of the isometric 
contraction irrespective of whether the force was increased or reduced. The coefficients were 
positive and significantly different from zero, showing a significant gradual increase (contra 
LFP: Z(R) = 1.6, p = 0.006, t17 = 3.1, ipsi LFP: Z(R) = 2.3, p < 0.001, t17 = 4.6, contra M1: 
Z(R) = 1.7, p = 0.002, t17 = 3.6, ipsi M1: Z(R) = 1.2, p = 0.029, t16 = 2.4). This demonstrates 
that in all regions, beta power began recovering before the force adjustment was completed. 
To test if the gradual beta recovery differed between change directions, hemispheres and 
nuclei, we performed again a 2x2 ANOVA with GPi/STN as between-subjects factor. No 
significant main effects or interactions were found (see Supplementary Table 2). The 2*2 
ANOVA with the reduced subset of patients and factors medication (ON/OFF) and change 
direction (increase/reduced) also showed no significant effects (see Supplementary Table 
2). This suggests that the gradual beta power recovery before the adjustment was completed 
was generally present during force adjustments, irrespective of direction. As the adjustment 













may be related to the absolute change in force – the absolute force rate. 
 
Beta power recovery before the force adjustment was completed was associated with an 
increased burst probability  
Fig. 3 shows that the average beta power was higher towards the end of a pressure change 
compared to the beginning but it is not clear if the average increase is due to an increased 
probability of high-amplitude beta events (= beta bursts) or an increased peak amplitude of 
these events. To help distinguish between these two options, we investigated how beta burst 
probability and peak amplitude varied from the beginning to the end of each pressure change 
in the contralateral LFP. We found that the probability of beta bursts was significantly higher 
in the second half compared to the first (ONH2-H1: 3.0%, p = 0.034, t17 = 2.3; OFFH2-H1: 6.7%, 
p = 0.008, WSR-test (n=11)) and that the peak amplitude of these events did not differ (ONH2-
H1: 47%, p = 0.227, t16 = 1.3; OFFH2-H1: 57%, p = 0.224, t8 = 1.3; dfs were reduced here as 
some halves did not contain any bursts). 
 
Low force rates coincided with high beta power  
Examples of single trials illustrated that high beta power could coincide with lower force 
rates not just towards the end but also midway through a force adjustment (Supplementary 
Fig. 1). Correlations between beta power and the simultaneously measured absolute force rate 
(see Methods section on “Correlation between beta power and force”) were highly significant 
at the group level (ON: mean rho = -0.06, p < 0.001, t17 = -4.7; OFF: mean rho = -0.08, p = 
0.009, t10 = -3.3). The negative correlation shows that when beta power was high, the 













We also tested if this correlation is significant against a permutation distribution that controls 
for the tendency of beta power being high towards the end of an adjustment, where slowing 
was often observed. It was still significant (ON: perm p = 0.002; OFF: perm p = 0.002). 
Finally, we repeated the same analysis using the force level instead of the absolute force rate. 
No significant correlation was present for the force level (ON: mean rho = 0.01, p = 0.184, 
WSR-test (n=18), perm p = 0.262; OFF: mean rho = 0, p = 0.996, t10 = 0, perm p = 0.956). 
 
Beta power was higher before the correct force level was reached when it was not followed 
by overshoot 
The increased amplitude of beta oscillations before the end of a force adjustment may play a 
role in slowing down and stabilizing muscle activity just before the correct force level is 
reached. If this was the case, beta power should be relatively reduced when a force 
adjustment ended with an overshoot. Indeed, when we compared beta power within the final 
400ms before the force adjustment ended (when no overshoot was present, versus the 400ms 
before the force change reversed when the target force was overshot), we found that beta 
power in the contralateral STN/GPi was significantly lower when the target was overshot in 
both medication conditions (ON: p = 0.001, t17 = -4.0, OFF: p = 0.016, t10 = -2.9, also see 
Supplementary Fig. 6). ON medication, this was also the case in the contralateral M1 and 
ipsilateral LFP (ON: contra M1: p = 0.021, t17 = -2.5, ipsi LFP: p = 0.006, t17 = -3.2). Note 
that adjustments that ended with an overshoot were less common than those that ended more 
accurately (% overshoot trials ON: 41%, OFF: 36%).  
In a similar vein, we also assessed if trials, in which beta activity was high, resulted in less 
overshoot at the end of a force adjustment. We median-split trials into high and low beta 
power trials, and found that this was the case for the contralateral LFP and M1 (ON: contra 













0.008, t17 = 3.0, ipsi M1: p = 0.300, t16=1.1; OFF: contra LFP: p = 0.009, t10 = 3.2, ipsi LFP: p 
= 0.496, t10 = 0.7, contra M1: p = 0.100, t10 = 1.8, ipsi M1: p = 0.048, t9 = 2.3). 
 
Note, though, that the force adjustments that ended with an overshoot were also distinct in 
other properties. Overshoots were stronger when the peak force rate was higher (both p < 
0.001, ON t17 = 7.5, OFF t10 = 5.4, pooled across increases and reductions) and when the 
amount of force change was smaller (both p < 0.001, ON t17 = -4.3, OFF t10 = -6.4).  
 
Beta M1-STN/GPi phase coupling decreased at the onset of force adjustments when 
dopamine levels were relatively restored  
Several studies have shown significant coupling between motor cortical regions and the basal 
ganglia at beta frequencies (Hirschmann et al., 2011; Litvak et al., 2011; Oswal et al., 2016; 
Tinkhauser et al., 2018; van Wijk et al., 2017). Thus, the difference in peak force rate 
between the ON and OFF medication condition may also be accompanied by differences in 
coupling between M1 and the basal ganglia nuclei. Phase coupling strength was quantified by 
computing inter-site phase clustering (ISPC) values across time separately for each trial (see 
Methods). 
First, we tested if coupling strength was significantly higher than that observed by chance by 
comparing the original ISPC values against a null-distribution created by shuffling the trial-
to-trial-association between the LFP and EEG signals 500 times. For example, the LFP signal 
from trial 1 was paired with the EEG signal from trial 5. For each of the 500 permutations the 
trial order of the EEG signal was completely shuffled before re-pairing it with the LFP signal. 
ISPC values were computed within 600ms long windows centred around the following five 
points: 1s before the start of the force adjustment, at the start, at the mid- point of the 













because if beta oscillations in both sites are relatively regular for several cycles, permutation-
ISPC values would also be relatively high (despite permuting the trials) when windows are 
small and contain only a small number of cycles.  
Fig. 4A shows significant coupling 1s before the force adjustments started and immediately 
afterwards in both the ON and OFF medication conditions. When dopamine levels were 
relatively restored (ON medication), beta coupling decreased at the onset of the adjustment to 
a level where coupling strength did not exceed the chance level (p-value above 0.05). When 
dopamine levels were low in the OFF medication condition, the reduction in coupling was 
less pronounced and that which did occur was delayed to around the mid-points of the force 
adjustments.  
 
Next, we tested directly if coupling was significantly lower at the beginning of force 
adjustments compared to the end (pooled across force increases and reductions) and if this 
reduction in coupling at the onset of adjustments, also further referred to as “decoupling”, 
was stronger ON medication. ISPCs were computed for each trial in a 200ms window 
directly after the adjustment began and in a 200ms window directly before it ended. We 
found that ON medication, coupling was significantly lower at the beginning of the 
adjustment compared to the end (Fig. B, ON: p = 0.001, t17 = -4.2; OFF: p = 0.623, t10 = -0.5). 
Additionally, when directly comparing ON versus OFF medication, the amount of decoupling 
at the beginning was significantly stronger ON medication (StartON-OFF: p = 0.024, t10 = -2.7). 
This difference was again present to a similar extent in both basal ganglia nuclei (two-sample 
t-test on the ON-OFF ISPC differences between the GPi and STN: p = 0.467, t9=0.76). 
Beta decoupling at the onset of force adjustments was similar for increases and reductions 
(Supplementary Fig. 7), but the difference in coupling strength between ON and OFF 













behavioural difference in the peak force rate was found. The differences in coupling strength 
were specific for the contralateral hemisphere as no differences were present in coupling 
between beta from the contralateral LFP and ipsilateral M1 or the ipsilateral LFP and 
ipsilateral M1 (Supplementary Fig. 8+9).  
 
When the peak force rate was high, cortico-basal ganglia beta phase-coupling was reduced – 
but only ON medication 
To test if the peak force rate itself was related to coupling strength, we median-split trials into 
slow and fast force adjustments. The median-split was performed separately for the ON and 
OFF medication condition. We only included trials in which the force was changed into the 
correct direction without any inadvertent initial changes into the wrong direction. Coupling 
was much reduced during faster compared to slower force adjustments, which was again 
specific to the ON medication condition and the contralateral hemisphere (Fig. 5, ON p = 
0.003, t17=-3.4, OFF p = 0.477, t10=0.7). This difference was not just due to the reduced 
sample size in the OFF medication condition, because for a reduced set of patients the 
difference still was significant in the ON medication recordings (subset ON: p = 0.042, t10=-
2.3). 
Note that the difference in peak force rate between fast and slow trials also was significantly 
higher ON medication (mean difference ON = 2.0 N/s, OFF = 1.7 N/s, p = 0.012, t10=3.1), 
indicating a broader range of force rates. 
When comparing beta power instead of beta coupling between trials with low and high peak 
force rates, a power difference in the contralateral STN/GPi was only observed OFF 
medication: Local beta power was earlier and more strongly suppressed when the adjustment 














To corroborate our finding of a relationship between the absolute rate of the force adjustment 
and inter-regional coupling, we computed within-subjects correlations between the peak force 
rates and ISPCs as well as local power (in a 0.2s long window starting at the onset of the 
force adjustment). In line with the above findings, the second-level test to see if the 
correlations significantly differed from zero showed that ON medication, the peak force rate 
was significantly correlated with the coupling strength (ON: mean rho = -0.07, p = 0.028, t17 
= -2.4), which was not the case OFF medication (OFF: mean rho = 0.05, p = 0.364, t10 = 1.0). 
Instead, OFF medication, the peak force rate correlated consistently with power in the 
contralateral STN/GPi (mean rho = -0.14, p = 0.003, t10 = -3.9) and slightly less with power 
in contralateral M1 (mean rho = -0.12, p = 0.045, t10 = -2.3). These correlations with beta 
power were not significant when patients were ON medication (contra LFP: mean rho = -
0.07, p = 0.054, t17 = -2.1, contra M1: mean rho = -0.04, p = 0.329, t17 = -1.0). A summary of 
all key findings is shown in Fig. 6. 
Finally, to test if the ON-medication correlation between the peak force rate and ISPCs would 
be diminished when controlling for local power, we computed partial correlations. The effect 
diminished only slightly when controlling for power from the contralateral M1 (mean rho = -
0.06, p = 0.037, t17 = -2.3) and the contralateral STN/GPi (mean rho = -0.06, p = 0.064, t17 = -
2.0).  
These findings suggest distinct effects of dopamine depletion on cortico-basal ganglia beta 
coupling and local beta power. Altogether, this indicates that when dopamine levels are low, 
beta coupling between the contralateral M1 and the basal ganglia is less flexibly modulated, 
associated with a reduced dynamic range of how fast the adjustments were performed. When 
patients were off medication, long-range coupling was not significantly modulated, which 













were accompanied by differences in local beta synchronization, particularly in the 
contralateral STN/GPi.  
Taken together, beta power and beta coupling were relatively suppressed at the onset of force 
adjustments but already began recovering before they ended and postural stabilization set in. 
Power suppression was strongest when the force was reduced, which was performed faster. 
Cortico-basal ganglia beta phase decoupling at the onset of force adjustments was significant 
only ON medication, thus after dopamine withdrawal the flexibility of cortico-basal ganglia 




Finally, we performed several control analyses. Larger force adjustments tend to be 
performed faster, which was also the case in our task (correlation between the amount of 
force change and peak force rates: mean rho ON = 0.52, OFF = 0.56, both p <0.001). But 
importantly, no beta power differences were found in the contralateral LFP when splitting 
trials into small and large force changes (Supplementary Fig. 11). The strength of cortico-
basal ganglia beta coupling also was not significantly modulated by the amount of force 
change (Supplementary Fig. 12).  
Larger force changes also tended to take longer (mean rho ON = 0.44, OFF = 0.39, both p < 
0.001). Additionally, the rate of the force adjustments and their duration was anti-correlated: 
When force adjustments were performed slowly, they took longer (mean rho ON = -0.22, 
OFF = -0.25, both p < 0.001). When dividing them into adjustments with short and long 
durations, a difference similar to the one when median-splitting trials according to the peak 
force rate was found in the OFF medication condition: Beta power was higher when the 













cortico-basal ganglia coupling was not significantly modulated by differences in duration 
(Supplementary Fig. 14).  
Finally, we evaluated if the peak force rate differed between trials in which a visual distractor 
stimuli (a second box coloured red instead of blue) was present or not. No significant 
differences were found (ON increase: p = 0.173, t17 = 1.4; ON reduction: p = 0.616, WSR-test 
(n=18), OFF increase: p = 0.753, t10 = -0.3; OFF reduction: p = 0.655, t10 = -0.5). 
Discussion 
Our task required patients to perform relatively small, finely controlled force adjustments 
while continuously maintaining an active muscle tone to hold the pen and apply the visually 
cued force level. We found that beta LFP power in the STN/GPi and cortico-basal ganglia 
phase coupling was suppressed at the onset of force adjustments and that the change was 
greater ON dopaminergic medication than OFF medication, in line with previous reports 
(Androulidakis et al., 2007; Devos et al., 2006; Doyle et al., 2005).  
We also showed a gradual beta power increase before the force adjustment was completed, 
which may be linked to the controlled nature of the cued adjustments, as will be discussed in 
more detail below.  
 
Beta power suppression does not relate to the absolute applied force but to the force rate 
Beta power suppression occurs during movement and has been shown to be larger for actions 
that generate higher force levels (Fischer et al., 2017a; Tan et al., 2015, 2013). However, 
rather than being inversely related to the force levels, we found beta suppression to be related 
to the absolute force rate for both force increases and reductions. Thus, beta oscillations may 
be related to a directionless measure, such as the rate of any change in force or, more broadly, 
the movement effort – or subjective gain of a motor command (Tan et al, 2015). In addition, 













when it was increased. Beta power decreased more strongly when the force was reduced, 
consistent with the hypothesis that beta power suppression reflects the absolute force rate 
rather than the force level.  
 
Beta activity returned before the force adjustments were completed and was associated with 
a reduced force rate and more precise completion  
For both directions of force adjustments, we saw a gradual recovery of beta power before the 
adjustment was completed in the trial average. Our paradigm was remarkable for the 
controlled nature of isometric force adjustments – performance accuracy was stressed by the 
examiner, and visual feedback was continuously provided to enable patients to produce the 
cued target force with high accuracy. Accordingly, force adjustments took on average longer 
than 600ms, despite the relatively small changes in force. The fact that an increase in beta 
activity occurred before the adjustment was completed raises two non-exclusive possibilities. 
First, it may play an active role in slowing down the adjustment and, in line with this, the 
elevated STN/GPi beta power coincided with a slowing of the force rate. Second, the increase 
in beta power occurring before the force adjustment was completed may play a role in the 
integration of visual and proprioceptive feedback to achieve accurate visuo-motor control 
(Tan et al., 2014b). The latter idea stems from studies on sensorimotor adaptation  (Tan et al., 
2016, 2014b; Torrecillos et al., 2015), which have led to the hypothesis that a post-movement 
increase in beta activity is linked to integration of sensory information and updating of an 
internal forward model (Cao and Hu, 2016). Both ideas are consistent with our observation 
that beta power was lower before patients overshot the target force, i.e. when they failed to 
stabilize the adjustment fast enough. In the periods of sustained, stable isometric contraction, 













This again implies that suppression of beta oscillations does not merely occur when muscles 
are tonically contracted but only when the strength of the contraction is adjusted. 
 
Cortico-basal ganglia beta phase coupling was more readily modulated ON medication  
We also investigated changes in long-range motor-cortical-basal ganglia beta phase coupling 
and found evidence to suggest different organisation of processing ON and OFF medication. 
We demonstrated that beta phase coupling was significantly reduced at the start of the force 
adjustments when patients were ON medication. This was specific to M1-STN/GPi coupling 
in the contralateral hemisphere. Stronger decoupling was associated with a higher peak force 
rate when patients were ON medication. OFF medication, we only saw differences in local 
STN/GPi power. This suggests that cortico-basal ganglia beta coupling is more dynamic 
when dopamine levels are relatively restored. The improved flexibility in coupling in turn 
may underscore the larger dynamic range of force rates observed in the ON medication state.  
Notably, ON medication, slow and fast force adjustments were not associated with 
pronounced differences in local beta power. This points towards the relative independence 
between long-range phase coupling and local beta activity, which may be unmasked in this 
study because of the special nature of the fine motor control task.  
 
An interesting observation is that early symptoms of Parkinson’s disease often include 
handwriting impairments (Pinto and Velay, 2015; Rosenblum et al., 2013). Handwriting 
requires fine control over the hand. Considering that we observed an impaired dynamic range 
of task-related cortico-basal ganglia beta phase decoupling when dopamine levels were low, 
an early feature of Parkinson’s disease may be pathological alterations in the dynamic range 
















Several limitations in our study are worth highlighting. First, we cannot establish causality in 
any of the relationships evidenced in this observational study. Second, we recorded motor 
cortical EEG activity and local field potentials from the STN or the GPi, depending on each 
patient’s implantation target. As none of our comparisons indicated differences between the 
STN and the GPi, in agreement with previous reports of similar beta modulation between the 
two structures (Brücke et al., 2012; Joundi et al., 2012), we did not distinguish between the 
two sites. However, it could be argued that we were underpowered to detect any but the 
biggest differences in LFP reactivity between the two targets. Third, as we were primarily 
interested in the force dynamics, we pooled the data across all trials irrespective of the 
presence of a visual distractor. However, to be sure that this was not a confounding factor, we 
computed a control analysis and showed that the presence of a distractor did not result in 
significant differences in force rates. Fourth, we cannot categorically ascribe the beta band 
changes observed here to the STN or GPi alone. This is particularly the case for the eight 
wide-field bipolar signals that were included in a small group of subjects because beta 
modulation was more pronounced than in more focal contiguous bipolar contacts. 
Finally, we did not detect any significant gamma power increase in our task, probably 
because the required force adjustments were too small (Tan et al., 2013). Past studies 
involving large, ballistic movements have related STN gamma and not beta power to 
movement speed (Joundi et al., 2012; Lofredi et al., 2018). Our continuous low-force tracking 
task may have made it possible to detect more subtle changes in beta activity while larger 















We have demonstrated that small, controlled force adjustments are accompanied by initial 
beta desynchronization followed by increased beta activity closer to completion of the 
adjustment. Cortico-basal ganglia beta phase coupling was significantly reduced at the start 
of an adjustment, but only ON and not OFF medication, suggesting that the dynamic range of 
cortico-basal ganglia coupling is impaired during dopamine withdrawal. Beta power 
suppression and phase decoupling was most closely linked to the rate of the force adjustments 
and not the force level per se. The appearance of beta synchronization instead may be linked 
to the timely and precise stabilization of force that is required to perform the present 
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Figure 1 Examples of the pen force recordings. A Patients controlled the size of a black 
square on the screen to match a blue square by varying the force of a pen on a graphics tablet. 
In the example the force needs to be further increased to expand the black square. B The grey 
line with sharp jumps shows the target force and the red line shows the force applied by 
regulating the force of a pen on a graphics tablet. The black crosses show the start and end 
points of an adjustment. C Behavioural results: Peak (absolute) force rate, adjustment 
durations and reaction times (RT). For all measures, four pairwise comparisons were 
performed: ON Increase vs. ON Decrease, OFF Increase vs. OFF Decrease, ON Increase vs. 
OFF Increase, ON Decrease vs. OFF Decrease. P-values are FDR-corrected to correct for 
multiple comparisons. 
 
Figure 2 Beta power decreased at the time of a force adjustment. The data are aligned to 
the midpoint of each force adjustment, averaged across all bipolar channels in the ON 
medication condition. Power in each frequency band was normalized by the median of each 
session. The black outlines show significant clusters obtained with a cluster-based 
permutation procedure for multiple comparison correction (p<0.05). Black arrows indicate 
the average time of the visual cue change. 
 
Figure 3 Baseline-normalized beta power decreased at the beginning of a force 
adjustment, regardless of direction, but gradually increased already before the 
adjustment was fully completed. Force increases and reductions were compared with a 













period and significant differences in beta power are shown as shaded areas in red. Relative 
beta power was suppressed by both force increases and reductions, but in the contralateral 
STN/GPi it stayed significantly more suppressed throughout the adjustment when the force 
was reduced. Note that the actual time that passed between the start and end of the 
adjustments was less than one second and varied across trials (see Methods on the temporal 
subdivision of the force adjustments). The force traces have been normalised between 0 and 1 
before averaging. 
 
Figure 4 Contralateral M1-STN/GPi beta phase coupling. A P-values below 0.05 show 
that coupling was significant compared to a permutation distribution (also after FDR-
correction). Note that ON medication (left), decoupling (where p>0.1) took place earlier, 
already at the start of an adjustment, than OFF medication (right), where decoupling was 
weaker and most pronounced in the middle of the adjustments. B When patients were ON 
medication, phase coupling between the contralateral BG nuclei and M1 was significantly 
reduced in the first 200ms of a force adjustment compared with the final 200ms (left). 
Positive differences are plotted in green, negative differences in black. The degree of 
decoupling in these first 200ms was significantly stronger ON medication compared with 
OFF medication (right).   
 
Figure 5 Low and high peak force rates relate to differences in coupling strength ON 
medication, and to differences in local beta power OFF medication. Only contralateral 
M1-STN/GPi coupling was significantly lower when force adjustments were rapid and 
patients were medicated (top left). Positive differences are plotted in green, negative 
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 Basal ganglia LFPs were recorded during continuous visuo-motor force control 
 Beta power decreased when the force was increased but also when it was reduced 
 Beta power was inversely related to the absolute force rate 
 Cortico-basal ganglia beta coupling was more readily modulated ON dopamine  
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